Cellular Immunotherapy of Malignancies Using the Clonal Natural Killer Cell Line NK-92-Reference-Cited by-同舟云学术

Cellular Immunotherapy of Malignancies Using the Clonal Natural Killer Cell Line NK-92

Published:2001-08 Issue:4 Volume:10 Page:535-544
ISSN:1525-8165
Container-title:Journal of Hematotherapy & Stem Cell Research
language:en
Short-container-title:Journal of Hematotherapy & Stem Cell Research

Author:

Tonn Torsten¹,Becker Sven²,Esser Ruth³,Schwabe Dirk³,Seifried Erhard²

Affiliation:

1. Institute for Immunhematology and Transfusionmedicine, Red Cross Blood Donor Service Hessia, Frankfurt/Main, Germany; Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Franfurt am Main, Germany

2. Institute for Immunhematology and Transfusionmedicine, Red Cross Blood Donor Service Hessia, Frankfurt/Main, Germany

3. Pediatric Hematology and Oncology, Johann Wolfgang Goethe-University, Frankfurt/Main, Germany.

Publisher

Mary Ann Liebert Inc

Subject

Hematology,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/15258160152509145

Reference57 articles.

1. Biology and Genetics of Hybrid Resistance

2. Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo.

3. Distinct Phenotypic and Functional Characteristics of Human Natural Killer Cells Obtained by Rapid Interleukin 2-Induced Adherence to Plastic

Cited by 228 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Anti-Cancer Immune Response by Acidosis-Sensitive Nanobody Display;The Journal of Membrane Biology;2024-09-10

2. Reprogramming natural killer cells for cancer therapy;Molecular Therapy;2024-09

3. Enhancing Anti-Cancer Immune Response by Acidosis-sensitive Nanobody Display;2024-08-16

4. The Spectrum of CAR Cellular Effectors: Modes of Action in Anti-Tumor Immunity;Cancers;2024-07-22

5. Off-the-shelf CAR-NK cells targeting immunogenic cell death marker ERp57 execute robust antitumor activity and have a synergistic effect with ICD inducer oxaliplatin;Journal for ImmunoTherapy of Cancer;2024-07